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Conclusion: In STEMI patients treated with primary PCI, increased admission serum
creatinine was strongly associated with 12-month mortality and CIN.
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Background: The aim of study is to compare the 4 years clinical outcome of stent
implantation with bare metal stent (BMS), first generation (sirolimus-eluting and
paclitaxel eluting stent: 1st DES) and second generation (Xience V and Nobori: 2nd
DES) drug-eluting stent implantation in chronic renal failure with dialysis (CRF-HD).
Methods: A prospective analysis of 898 CRF-HD patients with CAD (288 BMS, 311
1st DES and 299 2nd DES) in five high volume Asian centers after successful stenting
was performed. The study endpoints were all cause of death and major adverse cardiac
events (MACE: death, MI, CABG, CV event and re-PCI) at 4 years.
Results: The baseline clinical characteristics between 3 groups were similar. See
figures for clinical results.
Conclusion: The use of 2nd generation drug-eluting stents in patient with CRF-HD
was significantly lesser incidence of MACE than that of BMS at 4 years.
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Effectiveness of Theophylline in Prevention of Contrast-Induced Nephropathy
in Risky Egyptian Patients Undergoing Elective Coronary Angiography or
Percutaneous Intervention: A Randomized Controlled Trial
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Background: Contrast-induced nephropathy (CIN) is the third most common cause
of hospital acquired acute renal failure and is associated with increased morbidity and
mortality. Among risky patients, only intravenous (IV) hydration has proved effective
for prevention. The use of theophylline, a selective renal adenosine antagonist has
yielded conflicting results. The aim of this study was to examine the effectiveness of
theophylline in prevention of CIN when added to IV hydration and N-acetylcysteine
(NAC) in moderate and higher risk patients.
Methods: Sixty patients with stable serum creatinine and at least moderate risk for
CIN according to Mehran’s risk score were included in this parallel-group, 1:1, single-
blind, randomized controlled trial. Patients were randomized to IV hydration (1ml/kg/h
for 24 h), NAC (600 mg bid for 2 days), plus placebo (group P) or IV hydration, NAC,
and Theophylline (200 mg in 100 ml 0.9% saline, as IV infusion 30 minutes before
contrast-medium (CM) administration) (group T). Patients underwent standard
coronary angiography +/- angioplasty. Serum creatinine (SCr) was assessed just before
and 72 h after contrast administration and estimated glomerular filtration rate (eGFR)
was calculated according to the Modification of Diet in Renal Disease (MDRD)
formula. CIN was defined as an increase in SCr concentration of >= 0.5 mg/dl or >=
25% after 72 h of CM injection.
Results: Among group P, 6 patients (20%) developed CIN while none of the patients
in group T developed CIN. Theophylline also significantly decreased SCr (p=0.0001)
and increased eGFR (p=0.001) at 72 hours. Regression analysis showed that anemia,
chronic renal impairment, high CM dose, and advanced age were independent
predictors for deteriorating renal function after CM administration.
Conclusion: Theophylline seems to be an effective prophylaxis against CIN for
moderate and higher risk patients undergoing coronary angiography or angioplasty. It
offers additive protection when added to IV hydration and NAC.
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Baseline Renal Dysfunction is Associated with Worse Outcomes in Patients
Undergoing Primary Percutaneous Coronary Intervention for ST-elevation
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Background: Renal dysfunction is associated with worse mortality following acute
coronary syndromes. However there is a paucity of data assessing this relationship
after primary PCI (PPCI) for STEMI.
Methods: Prospective data upon 1503 patients who underwent PPCI at a tertiary
cardiac centre between 2004 and 2010 was analysed. Patients were grouped by
estimated glomerular filtration rate (eGFR) (calculated using the modified diet in renal
disease equation) into chronic kidney disease stage 4 (CKD4) (eGFR 15 to 30 ml/min),
CKD3b (eGFR 30 to 45 mls/min), CKD3a (eGFR 45 to60 mls/min) and CKD1/2
(eGFR>60mls/min). Mortality data was collected from the Office of National Statistics.
3-year composite of MACE (death, reinfarction, stroke and target vessel
revascularisation) were compared between groups.
Results: 25 patients were in the CKD4 group, 95 patients in the CKD3b group, 282
patients in the CKD3a group and 1101 patients in the CKD1/2group. Co-morbidity
including hypertension, diabetes mellitus, previous MI and left ventricular impairment
were more common in patients with lower eGFR. In hospital MACE was more frequent
in patients with lower eGFR(32% in CKD4 vs 13.7% in CKD3b vs 10.3% in CKD3a
vs 3.6 in CKD1/2, p<0.0001). Long term MACE was increased with declining eGFR
(OR=4.84, 95%CI 2.94 to 7.96, when comparing the highest and lowest eGFR
groups)(Figure.1). After adjustment renal function based on the eGFR at admission
remained a strong independent predictor of outcome.
Conclusion: Baseline renal dysfunction in patients undergoing primary PCI is
associated with an increased risk for combined death, re-infarction and recurrent
angina. This risk increases linearly with declining eGFR.
TCT-502
Cystatin C is superior diagnostic tool compared with conventional Serum
Creatinine or Estimated Glomerular Filtration Rate in prediction of Contrast
Induced Nephropathy
Hyuck Jun Yoon, Ji Hyun Sohn, Hong Won Shin, Ho Myung Lee, Hyun ok Cho,
Hyoung-Seob Park, Yun-Kyeong Cho, Chang-Wook Nam, Hyungseop Kim, Seung Ho
Hur, Yoon-Nyun Kim, Kwon Bae Kim
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Background: Impaired renal function is well known potent predictor of contrast
induced nephropathy (CIN). Serum creatinine and creatinine based estimated
glomerular filtration rate are the most commonly used biomarker of renal function, but
they have many limitation in accuracy. The purpose of this study is to evaluate whether
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Cystatin C based equation is superior to Creatinine based equation in prediction of
CIN.
Methods: We prospectively collected serum creatinine, Creatinine based estimated
GFR and serum Cystatin C 1day prior to CAG.
Results: From January 2009 to April 2011, 701 patients who received CAG and PCI
were enrolled in this study. Among the total 701 patients, CIN were developed in 24
cases (3.4%). In ROC analysis, the area under the curve for serum creatinine was 0.762
and area for MDRD was 0.763, but area of Cystatin C was 0.863 (p<0.05). Fair
discrimination for CIN was found at a Cystatin C level of 0.92, and at this value, the
sensitivity and specificity were 79.8% and 79.8%, respectively.
Conclusion: Cystatin C is superior method to predict high risk group of CIN than
serum creatinine or Creatinine based equation.
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Background: The Synergy between Percutaneous Coronary Intervention with Taxus
and Cardiac Surgery (SYNTAX) score predicts outcome in patients with multivessel
coronary artery disease randomised to PCI or bypass surgery but it has not been
assessed in a population with chronic kidney disease (CKD). These patients are
excluded from the majority of cardiology trials but often have multiple comorbidities
including diabetes mellitus (DM) and are at high risk for developing contrast induced
acute kidney injury (CI-AKI).
Methods: We recruited 262 patients with CKD (defined as eGFR< 60ml/min). This
included 208 patients with DM and 54 non-diabetic (ND) patients. CI-AKI was defined
as a rise in creatinine at day 3 of >25% from baseline or an absolute rise of 44.5 umol/l.
Severity of coronary disease was assessed using the SYNTAX score and calculated
independently by 2 observers. N-acetylcysteine and iv hydration were given to all
patients with eGFR <50ml/min in accordance with local guidelines.
Results: 39 (18.8%) of patients with DM developed CI-AKI compared to 7 (12.9%)
ND patients (p=NS). Age of patients who developed CI-AKI between DM and ND
was not significantly different. The contrast dose was similar in the CI-AKI and non
CI-AKI groups for both DM and ND (p=NS). The mean SYNTAX score in patients
with DM did not differ between those who did and did not develop CI-AKI (25.0 vs
19.1, p=NS). In the ND patients the mean SYNTAX score did not differ significantly
between the CI-AKI and non CI-AKI patients (12.2 vs 9.0, p=NS). In both DM and
ND the pre-procedure creatinine was significantly higher in patients who developed
CI-AKI. For DM creatinine 162.3 umol/l vs 140.4 umol/l (p=0.027); for ND 251 umol/l
vs 131 umol/l (p=0.01).
Conclusion: Although DM patients had more complex coronary disease with a higher
SYNTAX score than ND,the rate of CI-AKI was not increased in this group. Severity
of coronary artery disease does not therefore reflect risk of developing CIN. However
pre-procedure creatinine is strongly significant for predicting development of CIN in
both DM and ND patients.
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Clinical impact of renal function recovery after contrast induced nephropathy
on long-term adverse event
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Background: Contrast induced nephropathy (CIN) has been associated with increased
in-hospital morbidity and mortality as well as long-term mortality. However,
considerable numbers of CIN patients recover their renal function within several days
to several months without any sequelae. Moreover, the relationship of renal function
after CIN to long-term adverse events (AEs) is still unknown.
Methods: Database about the patients who underwent elective percutaneous coronary
intervention(PCI) from May 2008 to January 2010 were reviewed and we 471
identified patients who had follow-up serum Creatinine (sCr) within 1-3 months after
PCI. CIN was defined as absolute increase of sCr > 0.5 or relative increase of > 25%
within 72hrs after PCI. The CIN patients were classified as CIN-recover group
(differences of sCr between baseline and FU sCr < 0.3 mg/dL, n=14) or CIN-non-
recover group (FU sCr – Baseline sCr ≥ 0.3mg/dL, n=13). During 2yrs follow up, we
assessed AEs included death, myocardial infarction, stroke, end-stage renal disease,
percutaneous coronary revascularization, coronary artery bypass surgery and
development of pulmonary edema.
Results: 72 (15.0%) of the 471 patients experienced AEs. The incidence of AEs was
significantly higher in the CIN group (33.3%) than in the non-CIN group (13.9%)
(p<0.001). Among the CIN patients, CIN recover group (14.3%) showed similar
incidence of AEs compare with non-CIN group. On multivariate analysis, the
differences of sCr between baseline and 1-3months follow-up was considered as
significantly independent predictor of AEs development (HR 1.759, p<0.001, 95% CI
1.301-2.378).
Conclusion: Development of CIN affected on long-term clinical course. However, the
patients with recovered renal function after CIN within 1-3 months showed similar
clinical course compared with non-CIN group. Follow-up sCr after CIN can be helpful
method to identify high risk patients.
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Contrast Induced Acute Kidney Injury In Patients Undergoing Primary
Angioplasty For Acute Myocardial Infarction. A Randomized Trial On
Hydration With Saline Or Bicarbonate
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Background: Contrast-induced acute kidney injury (CI-AKI) is an important
complication occurring after contrast media exposure, associated with increased
mortality. We evaluated the effect of different strategies of hydration on prevention of
CI-AKI in patients with STEMI undergoing primary PCI.
Methods: We enrolled 592 patients with STEMI undergoing PPCI, assigned to receive
standard or high dose infusion of saline or sodium bicarbonate (groups A, B, C, and
D). The primary end-point was the occurrence of AKI, defined as an increase in serum
creatinine (sCr) concentration of >25% from the baseline value within 72 hours after
PPCI.
Results: 107 patients (18.1%) met the criterion for AKI, without differences in
incidence among treatment groups. Age, LVEF, sCr, and shock resulted as independent
predictors of AKI (Table 1). 32 patients (5.6%) died by the end of follow-up (6-36
months), without differences in mortality among groups. Mortality resulted
significantly higher in patients with CI-AKI, 16% vs. 3,4% (Fig. 1). Independent
predictors of survival resulted age, shock, and CI-AKI (Table 2).
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